Global Prevalence of Psychological Distress and Comorbidity With Disorders of Gut-Brain Interactions
- 18 September 2023
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 119 (1) , 165-175
Abstract
INTRODUCTION: This study focused on defining the global prevalence of clinically relevant levels of psychological distress and somatic symptoms and the prevalence of coexistence between these symptoms and disorders of gut-brain interaction (DGBI). We also analyzed how clinically relevant psychological distress and somatic symptoms and coexistent DGBI are associated with health-related outcomes. METHODS: We included a representative sample of 54,127 adult participants (49.1% women; mean age of 44.3 years) from 26 countries worldwide. Participants completed an Internet survey (the Rome Foundation Global Epidemiology Study) with validated self-report questionnaires. RESULTS: Clinically relevant psychological distress and/or somatic symptom severity was reported by 37.5% of the sample. These participants had 4.45 times higher odds to have at least one DGBI than individuals without psychological distress and/or somatic symptoms. Compared with participants with psychological distress and/or somatic symptoms with vs without DGBI, participants with a DGBI reported increased healthcare and medication utilization (with OR from 1.6 to 2.8). Coexistent DGBI in participants with psychological distress and/or somatic symptoms was the variable most strongly associated with reduced mental (β = −0.77; confidence interval [−0.86 to −0.68]) and physical (β = −1.17; confidence interval [−1.24 to −1.10]) quality of life. DISCUSSION: This global study shows that psychological distress, somatic symptoms, and DGBI are very common and frequently overlap. The coexistence between psychological distress/somatic symptoms and DGBI seems to be especially detrimental to quality of life and healthcare utilization. Individuals with psychological distress/somatic symptoms and DGBI coexistence seem to be a group vulnerable to psychosocial problems that should be studied further and would likely benefit from psychological/psychiatric interventions.Keywords
Funding Information
- Rome Foundation Research Institute
- Ironwood Pharmaceuticals, Incorporated
- Shire
- Allergan
- Takeda Pharmaceuticals U.S.A.
This publication has 30 references indexed in Scilit:
- Anxiety and depression as markers of multiplicity of sites of functional gastrointestinal disorders: A gender issue?Clinics and Research in Hepatology and Gastroenterology, 2013
- Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general populationBMC Psychiatry, 2013
- Sex differences in the symptoms and psychological factors that influence quality of life in patients with irritable bowel syndromeEuropean Journal of Gastroenterology & Hepatology, 2012
- Psychopathological features of irritable bowel syndrome patients with and without functional dyspepsia: a cross sectional studyBMC Gastroenterology, 2011
- Comorbidity Patterns of Anxiety and Depressive Disorders in a Large Cohort StudyThe Journal of Clinical Psychiatry, 2011
- Factors associated with co-morbid irritable bowel syndrome and chronic fatigue-like symptoms in functional dyspepsiaNeurogastroenterology & Motility, 2011
- Novel associations with dyspepsia: a community‐based study of familial aggregation, sleep dysfunction and somatizationNeurogastroenterology & Motility, 2009
- Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveysThe Lancet, 2007
- Symptoms of depression and anxiety during adult life: evidence for a decline in prevalence with agePsychological Medicine, 1998
- Irritable bowel syndrome: The role of psychosocial factorsStress Medicine, 1994